Provided by Tiger Trade Technology Pte. Ltd.

NeOnc Technologies Holdings

3.03
-0.2850-8.61%
Volume:205.58K
Turnover:635.09K
Market Cap:87.14M
PE:-1.42
High:3.41
Open:3.41
Low:3.00
Close:3.31
52wk High:12.99
52wk Low:3.00
Shares:28.81M
Float Shares:15.86M
Volume Ratio:1.16
T/O Rate:1.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1361
EPS(LYR):-3.2036
ROE:--
ROA:-634.99%
PB:-4.02
PE(LYR):-0.94

Loading ...

NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA

GlobeNewswire
·
Yesterday

NeOnc CEO Heshmatpour Buys USD 115,400 in Company Stock

Reuters
·
Yesterday

Press Release: NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive Neo100 Phase 2a Results

Dow Jones
·
Yesterday

Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus

GlobeNewswire
·
Sep 15

Top Executive Makes Bold Insider Move at NeOnc Technologies Holdings

TIPRANKS
·
Sep 15

Insiders Continue Buying, as NeOnc Moves NEO100 Toward Its Next Regulatory Test

GlobeNewswire
·
Sep 14

Neonc Technologies CEO Amir F Heshmatpour Buys $135,620 of Common Shares

Reuters
·
Sep 14

Neonc Technologies - Announces $15 Mln Registered Direct Offering Priced At-the-Market

THOMSON REUTERS
·
Sep 09

Neonc Technologies - to Request Type B FDA Meeting for Neo100 Registrational Pathway

THOMSON REUTERS
·
Sep 09

NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data

GlobeNewswire
·
Sep 09

NeOnc Technologies Issues Warrants for 3,571,430 Shares in USD 15 Million Registered Direct Offering

Reuters
·
Sep 09

Neonc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules with New and Existing Institutional Investors

THOMSON REUTERS
·
Sep 09

Neonc Technologies - to Sell 3,571,430 Shares and Warrants at $4.20 Per Share

THOMSON REUTERS
·
Sep 09

Press Release: NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules with New and Existing Institutional Investors

Dow Jones
·
Sep 09

NeOnc' Phase 2 Data Could Put Cancer on the Ropes

GlobeNewswire
·
Sep 08

NeOnc Technologies Price Target Maintained with a $15.00/Share by BTIG

Dow Jones
·
Sep 08

NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger

GlobeNewswire
·
Aug 28

NeOnc’s Clinical Story Is Now the Main Event

GlobeNewswire
·
Aug 26

NeOnc Technologies Amends 8-K to Name Nasim Shomali to Audit Committee

Reuters
·
Aug 22

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 21